APA (7th ed.) Citation

M, W., JP, B., FM, B., C, D., C, E., K, G., . . . TL, R. (2026). Development and in vivo evaluation of 18F-labeled PET tracers covalently targeting KRAS-G12C for noninvasive cancer diagnosis and therapy monitoring. Theranostics, 16(12), 6485. https://doi.org/10.7150/thno.123741

Chicago Style (17th ed.) Citation

M, Willmann, et al. "Development and in Vivo Evaluation of 18F-labeled PET Tracers Covalently Targeting KRAS-G12C for Noninvasive Cancer Diagnosis and Therapy Monitoring." Theranostics 16, no. 12 (2026): 6485. https://doi.org/10.7150/thno.123741.

MLA (9th ed.) Citation

M, Willmann, et al. "Development and in Vivo Evaluation of 18F-labeled PET Tracers Covalently Targeting KRAS-G12C for Noninvasive Cancer Diagnosis and Therapy Monitoring." Theranostics, vol. 16, no. 12, 2026, p. 6485, https://doi.org/10.7150/thno.123741.